India, Aug. 18 -- Marksans Pharma announced that its wholly owned subsidiary Relonchem in UK has received Marketing Authorization for the below-mentioned products from UK MHRA:Metformin Hydrochloride Relonchem 500 mg Prolonged Release TabletsMetformin Hydrochloride Relonchem 750 mg Prolonged Release TabletsMetformin Hydrochloride Relonchem 1000 mg Prolonged Release Tablets
Published by HT Digital Content Services with permission from Pivotal Sources....